-+ 0.00%
-+ 0.00%
-+ 0.00%

ClearPoint Neuro director Matthew B. Klein disposes of 16,000 shares worth $185,440

PUBT·05/26/2026 20:31:18
Listen to the news
ClearPoint Neuro director Matthew B. Klein disposes of 16,000 shares worth $185,440
  • ClearPoint Neuro director Matthew B. Klein sold 16,000 shares on May 21, 2026 at a weighted average price of $11.59.
  • His direct holdings fell to 46,935 shares following the sale.
  • Klein also received 12,820 restricted stock units on May 21, 2026, each convertible into one common share at $0.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ClearPoint Neuro Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-239431), on May 26, 2026, and is solely responsible for the information contained therein.